![]() |
|||||||||||||||||||||||||
Input Your Idea or SolutionHave you been working on a fantastic new technology that may be a game-changer in Alzheimer’s management, treatment or diagnosis? Submit it here! Contact us if you would like to learn more and/or invest in these great solutions: Treatment for Alzheimer’s Disease: * A dialysis-type system for filtering out the harmful proteins (A-Beta, Tau) from Cerebrospinal Fluid (CSF) that accumulate in the brain and cause the cascade of events that lead to Alzheimer’s Disease. * Using RNA sequencing (genetic testing) to identify therapeutic targets that may yield a blood-based biomarker that can be used to monitor treatment efficacy. * Synthetic organic methodology with enantioselective drugs to treat Alzheimer’s Disease * A new drug, originally developed to treat diabetes, that can create a cognitive improvement in Alzheimer’s Disease patients. * The development of cell models for the rapid screening of drugs for their effects on the synthesis of certain proteins in the neurons. * Using advanced mathematical models to cure the disease. * Using yeast to model aging cells and test biochemicals that improve the turnover of amyloid beta. * Using newly discovered soluble receptors for certain proteins to establish the bio-activity of the hormones. * Using new information about lysosomes to decrease proteins at nerve receptors (where information is usually lost in Alzheimer’s patients). Diagnosis of Alzheimer’s Disease: * A new type of Virtual Scanning technology that can determine the broad range of pathologies which characterize Alzheimer’s Disease. * New insights into using erythrocytes (type of blood cell) to determine Alzheimer’s Disease diagnosis. * Using SNPs (single nucleotide polymorphisms – small changes in the DNA) to diagnose Alzheimer’s Disease. * Using hyperpolarized MRI and stable isotope chemistry to create a non-invasive, non-ionizing, neuroimaging technique to diagnose ALZ at a very early stage. Management of Alzheimer’s Disease: * Using trans-cranial alternating current as a means to manage Alzheimer’s Disease. * Looking at levels of AchE in the blood to determine the levels of toxicity that cause memory loss. |
Latest Signatures
|